Cary, NC, United States of America

Navdeep Balkrishna Malkar

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Navdeep Balkrishna Malkar in Pharmaceutical Sciences**

Introduction

Navdeep Balkrishna Malkar, an accomplished inventor based in Cary, NC, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of 17 patents, he has focused primarily on the development of compositions and methods for treating fungal infections, addressing critical health challenges through his inventive spirit.

Latest Patents

Among his most recent contributions are two notable patents related to compositions and methods for the treatment of fungal infections. These patents feature non-irritating pharmaceutical compositions containing CD101 in pharmaceutically acceptable salts, such as CD101 acetate, or in its neutral form. The innovative pharmaceutical formulations are designed to be intravenously administered to patients suffering from fungal infections like candidiasis, providing a potential new avenue for effective treatment.

Career Highlights

Navdeep's career encompasses a wealth of experience in prominent companies, including Biocon Limited and Cidara Therapeutics, Inc. These roles have provided him with a solid foundation in pharmaceuticals, enabling him to translate his research and development efforts into marketable solutions that address real-world problems.

Collaborations

Throughout his career, Navdeep has collaborated with notable colleagues, including Balasingam Radhakrishnan and Kenneth D. James. These partnerships have contributed to his innovative work, enhancing the development of effective therapeutic options in his field.

Conclusion

Navdeep Balkrishna Malkar stands out as a pioneering inventor whose work has the potential to transform the treatment landscape for fungal infections. With a commitment to advancing pharmaceutical science and a robust portfolio of patents, his contributions will likely continue to have a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…